27 May 2014
Twenty thirteen was a pivotal year for the MPP. The organisation strengthened its relationships with key stakeholders including communities living with HIV, international organisations, governments, civil society and industry to move forward key initiatives to increase access to HIV medicines in developing countries. Last year, the MPP signed three public health-focused agreements with ViiV Healthcare, Bristol-Myers Squibb and F. Hoffmann-La Roche. We also stepped up our work with generic manufacturers and are now managing more than two dozen sub-licensing projects with six companies.
Learn more about our work and our 2013 achievements: download the 2013 annual report (PDF)
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.